DEAD

Serial Number

97668321

Owner

Odyssey Therapeutics, Inc.

Attorney

Marie Lavalleye

Filing Date

Nov 8, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ODYSSEY THERAPEUTICS Trademark

Serial Number: 97668321

ODYSSEY THERAPEUTICS is a trademark filed by Odyssey Therapeutics, Inc. on November 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Odyssey Therapeutics, Inc. (7 trademarks)

51 Sleeper Street, Suite 800
Boston, MA 02210

Entity Type: 03

Legal Representation

Attorney of Record

Marie Lavalleye

545 trademarks filed View all →

Correspondence Address

Marie Lavalleye COVINGTON & BURLING LLP

ONE CITYCENTER, 850 TENTH STREET NW

WASHINGTON, DC 20001

United States

Trademark Details

Filing Date

November 8, 2022

Registration Date

Not Registered

Published for Opposition

October 24, 2023

Goods & Services

Providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, cancer, and auto-immune diseases; Development of molecules for use by others in developing and designing pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases

Pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases; Molecules used as a component in pharmaceutical preparations for the treatment of cancer and auto-immune diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 16, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Oct 16, 2025 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 22, 2024 EXRA

SOU EXTENSION 2 GRANTED

Oct 22, 2024 EX2G

SOU EXTENSION 2 FILED

Oct 22, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 22, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 30, 2024 EXRA

SOU EXTENSION 1 GRANTED

Jan 26, 2024 EX1G

SOU EXTENSION 1 FILED

Jan 26, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Jan 26, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 19, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 24, 2023 NPUB

PUBLISHED FOR OPPOSITION

Oct 24, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 4, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 18, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 15, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 15, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 15, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 28, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 28, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 28, 2023 CNRT

ASSIGNED TO EXAMINER

Aug 22, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 29, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 28, 2022 NWOS

NEW APPLICATION ENTERED

Nov 11, 2022 NWAP

Related Trademarks

More from this Owner

ODYSSEY THERAPEUTICS

Serial #98951749

More in Same Class

Serial #97667379

Serial #97668715